Avraham Frisch

Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice

Arie Apel, Yakir Moshe, Yishai Ofran et al. · American Journal of Hematology · 2021 · 32 citations

Medicine, Oncology, Pharmacology +15

Baseline Chest Computed Tomography for Early Diagnosis of Invasive Pulmonary Aspergillosis in Hemato-oncological Patients: A Prospective Cohort Study

Roni Bitterman, Emília Hardak, Marina Raines et al. · Clinical Infectious Diseases · 2019 · 30 citations

Medicine, Clinical Sciences, Oncology +17

Venetoclax in combination with FLAG-IDA-based protocol for patients with acute myeloid leukemia: a real-world analysis

Ofir Wolach, Avraham Frisch, Liat Shargian et al. · Annals of Hematology · 2022 · 26 citations

Medicine, Hematology, Oncology +6

Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia: a real-world, multi-center, matched analysis

Shai Shimony, Jonathan Canaani, Eitan Kugler et al. · Annals of Hematology · 2022 · 21 citations

Pharmacy, Oncology, Pharmacotherapy +12

Midostaurin in combination with intensive chemotherapy is safe and associated with improved remission rates and higher transplantation rates in first remission—a multi-center historical control study

Tamar Berger, Uri Rozovski, Yakir Moshe et al. · Annals of Hematology · 2019 · 18 citations

Medicine, Oncology, Pharmacology +8